Thornrose Ventures
Thornrose Ventures filed a registration for Aceso Plasma, Inc. on July 22, 2026.
Lobbying for Aceso Plasma, Inc. · Medical-device company developing non-thermal plasma technology for wound care.
-
JOHN MASON LONG New on this filingPreviously held: US Department of Health & Human Services, Special Assistant office of Intergovernmental and External Affairs
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.
Federal policies, programs, funding, procurement, research, and agency actions related to advanced wound care, non-thermal plasma medical devices, infection control, antimicrobial resistance, trauma care, battlefield medicine, medical-device development, and regulatory pathways.